Compound Detail
CHEMBL4065122
FENEBRUTINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1
Basic Information
| ChEMBL ID | CHEMBL4065122 |
| Name | FENEBRUTINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | WNEODWDFDXWOLU-QHCPKHFHSA-N |
3
Targets
21
Activities
3
Assay Types
17
PK Parameters
20
Publications
8
Known Names
6
Indications
1
Mechanisms
Molecular Properties
664.8
MW (Da)
3.57
ALogP
11
HBA
2
HBD
121.0
PSA (Ų)
0.31
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase BTK inhibitor | INHIBITOR | Tyrosine-protein kinase BTK | ✓ | ✓ |
Indications
Multiple Sclerosis Multiple Sclerosis, Chronic Progressive Arthritis, Rheumatoid Lupus Erythematosus, Systemic Urticaria Autoimmune Diseases
Activity Summary
IC50 13 meas. best 8.92
Ki 7 meas. best 9.05
Kd 1 meas. best 9.46
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK CHEMBL5251 | Kd | 9.46 | 9.46 | 0.3 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | Ki | 9.05 | 8.7071 | 0.9 | 7 |
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 8.92 | 8.3673 | 1.2 | 11 |
| Unchecked CHEMBL612545 | IC50 | 8.11 | 8.11 | 7.8 | 1 |
| TMD8 CHEMBL4296503 | IC50 | 7.9 | 7.9 | 12.6 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 27.4 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 9.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 7.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 9.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 14.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 22.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 314.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 12.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 29.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 9.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 21.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| F | 65.1 | % | Rattus norvegicus |
| F | 96.0 | % | Rattus norvegicus |
| F | 130.0 | % | Canis lupus familiaris |
| T1/2 | 2.2 | hr | Rattus norvegicus |
| Vd | 5.42 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine